Mizoribine - Misplaced Pages

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 02:11, 15 August 2011 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 02:11, 15 August 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound

Mizoribine
Clinical data

Other names	1--5-hydroxyimidazole-4-carboxamide
Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 5-hydroxy-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide
CAS Number	50924-49-7
PubChem CID	104762
UNII	4JR41A10VP
KEGG	D01392
CompTox Dashboard (EPA)	DTXSID8045777
ECHA InfoCard	100.164.876
Chemical and physical data
Formula	C₉H₁₃N₃O₆
Molar mass	259.21 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N
(verify)

Mizoribine (INN, trade name Bredinin) is an immunosuppresive drug. The compound was first observed in Tokyo, Japan, in 1971. It is a natural product, first isolated from the mould Eupenicillium brefeldianum.